Techniques for Usability Risk Assessment during Medical Device Design

Alice Ravizza, A. Lantada, Luis Ignacio Ballesteros Sánchez, Federico Sternini, C. Bignardi
{"title":"Techniques for Usability Risk Assessment during Medical Device Design","authors":"Alice Ravizza, A. Lantada, Luis Ignacio Ballesteros Sánchez, Federico Sternini, C. Bignardi","doi":"10.5220/0007483102070214","DOIUrl":null,"url":null,"abstract":"Human errors during the use of medical devices, due to pitfalls in the design of the user interface, may lead to substantial risk to users and to patients. There are multiple techniques for the identification and for the assessment of user related risks, that may be chosen according to the step of the design (preliminary feasibility studies, minimum viable product assessment, verification and validation) and considering cognitive processes and information processing mechanisms of users, which may lead to errors. Some techniques are more adequate for a quick-and-dirty approach, during early stages of design: these include expert reviews, discussions among focus groups, standard reviews and heuristic analyses. Other techniques are adequate for a more detailed and systematic analysis of risk, in more advanced design stages, with a failure mode and effect analysis (FMEA) approach, including time-and-motion studies and task analyses. Lastly, user tests with the help of rapid prototypes, perhaps involving alternative embodiments to be studied, are very adequate for verification and validation of the interface. Usability analysis techniques should be part of the toolbox of a biomedical engineer and they should be carefully chosen. Each technique, regardless the step it is used, should allow the designers to define a precise level of risk in terms of probability, severity. Moreover, usability risk minimisation measures shall be measurable and able to be quantified, as well as the impact of risk mitigation strategies. For this reason, usability risk minimisation measures should be classified according to regulatory requirements as “safe by design”; “alarms and protections” and “information for safe use”. Each class of risk minimisation measure should be then given a measurable risk reduction score, so that the risk assessment can be completed in a repeatable and regulatory compliant way.","PeriodicalId":357085,"journal":{"name":"International Conference on Biomedical Electronics and Devices","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Conference on Biomedical Electronics and Devices","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5220/0007483102070214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Human errors during the use of medical devices, due to pitfalls in the design of the user interface, may lead to substantial risk to users and to patients. There are multiple techniques for the identification and for the assessment of user related risks, that may be chosen according to the step of the design (preliminary feasibility studies, minimum viable product assessment, verification and validation) and considering cognitive processes and information processing mechanisms of users, which may lead to errors. Some techniques are more adequate for a quick-and-dirty approach, during early stages of design: these include expert reviews, discussions among focus groups, standard reviews and heuristic analyses. Other techniques are adequate for a more detailed and systematic analysis of risk, in more advanced design stages, with a failure mode and effect analysis (FMEA) approach, including time-and-motion studies and task analyses. Lastly, user tests with the help of rapid prototypes, perhaps involving alternative embodiments to be studied, are very adequate for verification and validation of the interface. Usability analysis techniques should be part of the toolbox of a biomedical engineer and they should be carefully chosen. Each technique, regardless the step it is used, should allow the designers to define a precise level of risk in terms of probability, severity. Moreover, usability risk minimisation measures shall be measurable and able to be quantified, as well as the impact of risk mitigation strategies. For this reason, usability risk minimisation measures should be classified according to regulatory requirements as “safe by design”; “alarms and protections” and “information for safe use”. Each class of risk minimisation measure should be then given a measurable risk reduction score, so that the risk assessment can be completed in a repeatable and regulatory compliant way.
医疗器械设计中可用性风险评估技术
在使用医疗器械过程中,由于用户界面设计中的缺陷而导致的人为错误可能会给用户和患者带来重大风险。用户相关风险的识别和评估有多种技术,可以根据设计的步骤(初步可行性研究、最小可行产品评估、验证和确认)进行选择,并考虑到用户的认知过程和信息处理机制,这可能会导致错误。在设计的早期阶段,一些技术更适合于快速和肮脏的方法:这些技术包括专家评审、焦点小组讨论、标准评审和启发式分析。在更高级的设计阶段,使用故障模式和影响分析(FMEA)方法,包括时间和运动研究和任务分析,其他技术足以进行更详细和系统的风险分析。最后,在快速原型的帮助下进行的用户测试,可能涉及要研究的替代实施例,对于界面的验证和确认是非常足够的。可用性分析技术应该是生物医学工程师工具箱的一部分,应该仔细选择。每种技术,无论使用哪一步,都应该允许设计师根据概率和严重性定义精确的风险级别。此外,可用性风险最小化措施以及风险缓解战略的影响应是可衡量和能够量化的。因此,可用性风险最小化措施应根据监管要求分类为“设计安全”、“警报和保护”和“安全使用信息”。每一类风险最小化措施都应该给出一个可衡量的风险降低评分,这样风险评估就可以以一种可重复的、符合法规的方式完成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信